Paul Chaney was Appointed as President, Chief Executive Officer at PanOptica

Date of management change: March 15, 2009 

What Happened?

Bernardsville, NJ-based PanOptica Appointed Paul Chaney as President, Chief Executive Officer

 

About the Company

At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.

 

About the Person

Paul Chaney is President, Chief Executive Officer at PanOptica. Previously, Paul held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Hill Nancy, Peng Dennis, Vinegar Rodney, Larson Carol, Elias Diana, Dominguez Nicole, Dykes Douglas, Gonzalez David, McLoughlin Joe, Solby Bruno, Dueck Danna

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.